Biomanufacturing Media

  1. CMC Challenges Facing Next-Generation ADCs 10/22/2025

    In this segment from the Bioprocess Online Live event “Evolving CMC Strategies To Enable Next-Gen ADCs,” panelists Michael Torres, Ph.D. (CrossBridge Bio), Morris Rosenberg, Ph.D. (CrossBridge Bio), and Borys Shor, Ph.D. (OS Therapies and Manhattan BioSolutions) weigh in on the biggest challenges to ADC development, particularly navigating geopolitical tensions in a time of increasingly global manufacturing operations.

  2. Advancing Allogeneic Cell Therapy for SCI and Blindness with Lineage's Brian Culley 10/22/2025

    On episode 114 of Cell & Gene: The Podcast, Host Erin Harris talks to Brian Culley, CEO of Lineage Cell Therapeutics, about advancing cell therapy beyond oncology and into transformative treatments for conditions such as spinal cord injury and blindness.

  3. Selective Degradation Of Cancer Target WDR5 10/17/2025

    Explore how to enable precise biophysical characterization of PROTACs targeting WDR5 to help overcome challenges with undruggable cancer proteins and complex interactions.

  4. How To Keep Your Degrader Pipeline Moving Forward 10/17/2025

    Discover a new biophysical method that simplifies PROTAC characterization, improves assay development, and delivers high-quality affinity data even for complex interactions.

  5. Chromatography Resins In Therapeutic Treatment Delivery 10/17/2025

    Explore how chromatography resins are evolving from purification tools to therapeutic agents in cancer treatment, with insights into their chemical properties and clinical potential.

  6. Assessing Production And Stability Of Antibody Drug Conjugate Platforms 9/24/2025

    ADCs with similar antibody sequences can behave differently due to linker and payload choices. Analytical tools reveal structural and stability differences critical to therapeutic performance.

  7. Streamlining Vaccine Purification: Techniques For Modern Modalities 9/23/2025

    Explore cutting-edge chromatography techniques accelerating vaccine purification across diverse modalities, with case studies on HPV, Malaria, and COVID-19.

  8. Transforming Nanoparticles By Continuous Manufacturing 9/13/2025

    Discover how continuous manufacturing of nanoparticles can improve process efficiency, reduce costs, and increase the quality of the final drug product.

  9. The Interoperability Challenge In Single-Use 9/12/2025

    In this segment from the Bioprocess Online Live event, “Single-Use Harmonization Needs A Tune Up,” our panelists define the main challenge plaguing single-use users: a lack of standards across systems and components. This absence of standardization creates a demand for deep, system-specific expertise that complicates interoperability across the industry and even within an organization. They discuss the many layers of nuance and complexity that make large-scale standardization difficult.

  10. Supplier Standards And Building Hybrid Single-Use Models 9/12/2025

    In this segment from the Bioprocess Online Live event, “Single-Use Harmonization Needs A Tune Up,” the panelists advise taking a unit operations approach to standardization. They also emphasize the growing trend of the plug-and-play hybrid models in single-use.